Dopexamine has been used in trials studying the diagnostic and treatment of Free Flap, Oral Cancer, Hypotension, Septic Shock, and Head and Neck Cancer.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Valsartan | Dopexamine may decrease the antihypertensive activities of Valsartan. |
| Ramipril | Dopexamine may decrease the antihypertensive activities of Ramipril. |
| Reserpine | Dopexamine may decrease the antihypertensive activities of Reserpine. |
| Remikiren | Dopexamine may decrease the antihypertensive activities of Remikiren. |
| Torasemide | Dopexamine may decrease the antihypertensive activities of Torasemide. |
| Isradipine | Dopexamine may decrease the antihypertensive activities of Isradipine. |
| Olmesartan | Dopexamine may decrease the antihypertensive activities of Olmesartan. |
| Chlorthalidone | Dopexamine may decrease the antihypertensive activities of Chlorthalidone. |
| Nitroprusside | Dopexamine may decrease the antihypertensive activities of Nitroprusside. |
| Diltiazem | Dopexamine may decrease the antihypertensive activities of Diltiazem. |
| Minoxidil | Dopexamine may decrease the antihypertensive activities of Minoxidil. |
| Treprostinil | Dopexamine may decrease the antihypertensive activities of Treprostinil. |
| Amlodipine | Dopexamine may decrease the antihypertensive activities of Amlodipine. |
| Nimodipine | Dopexamine may decrease the antihypertensive activities of Nimodipine. |
| Nisoldipine | Dopexamine may decrease the antihypertensive activities of Nisoldipine. |
| Bendroflumethiazide | Dopexamine may decrease the antihypertensive activities of Bendroflumethiazide. |
| Fosinopril | Dopexamine may decrease the antihypertensive activities of Fosinopril. |
| Trandolapril | Dopexamine may decrease the antihypertensive activities of Trandolapril. |
| Metolazone | Dopexamine may decrease the antihypertensive activities of Metolazone. |
| Lercanidipine | Dopexamine may decrease the antihypertensive activities of Lercanidipine. |
| Benazepril | Dopexamine may decrease the antihypertensive activities of Benazepril. |
| Bosentan | Dopexamine may decrease the antihypertensive activities of Bosentan. |
| Enalapril | Dopexamine may decrease the antihypertensive activities of Enalapril. |
| Cyclothiazide | Dopexamine may decrease the antihypertensive activities of Cyclothiazide. |
| Candoxatril | Dopexamine may decrease the antihypertensive activities of Candoxatril. |
| Mecamylamine | Dopexamine may decrease the antihypertensive activities of Mecamylamine. |
| Losartan | Dopexamine may decrease the antihypertensive activities of Losartan. |
| Moexipril | Dopexamine may decrease the antihypertensive activities of Moexipril. |
| Eplerenone | Dopexamine may decrease the antihypertensive activities of Eplerenone. |
| Lisinopril | Dopexamine may decrease the antihypertensive activities of Lisinopril. |
| Nitroglycerin | Dopexamine may decrease the antihypertensive activities of Nitroglycerin. |
| Metyrosine | Dopexamine may decrease the antihypertensive activities of Metyrosine. |
| Hydroflumethiazide | Dopexamine may decrease the antihypertensive activities of Hydroflumethiazide. |
| Cryptenamine | Dopexamine may decrease the antihypertensive activities of Cryptenamine. |
| Perindopril | Dopexamine may decrease the antihypertensive activities of Perindopril. |
| Candesartan cilexetil | Dopexamine may decrease the antihypertensive activities of Candesartan cilexetil. |
| Indapamide | Dopexamine may decrease the antihypertensive activities of Indapamide. |
| Tadalafil | Dopexamine may decrease the antihypertensive activities of Tadalafil. |
| Eprosartan | Dopexamine may decrease the antihypertensive activities of Eprosartan. |
| Chlorothiazide | Dopexamine may decrease the antihypertensive activities of Chlorothiazide. |
| Quinapril | Dopexamine may decrease the antihypertensive activities of Quinapril. |
| Telmisartan | Dopexamine may decrease the antihypertensive activities of Telmisartan. |
| Methyldopa | Dopexamine may decrease the antihypertensive activities of Methyldopa. |
| Hydrochlorothiazide | Dopexamine may decrease the antihypertensive activities of Hydrochlorothiazide. |
| Trichlormethiazide | Dopexamine may decrease the antihypertensive activities of Trichlormethiazide. |
| Irbesartan | Dopexamine may decrease the antihypertensive activities of Irbesartan. |
| Nitrendipine | Dopexamine may decrease the antihypertensive activities of Nitrendipine. |
| Deserpidine | Dopexamine may decrease the antihypertensive activities of Deserpidine. |
| Pentolinium | Dopexamine may decrease the antihypertensive activities of Pentolinium. |
| Trimethaphan | Dopexamine may decrease the antihypertensive activities of Trimethaphan. |
| Diazoxide | Dopexamine may decrease the antihypertensive activities of Diazoxide. |
| Captopril | Dopexamine may decrease the antihypertensive activities of Captopril. |
| Epoprostenol | Dopexamine may decrease the antihypertensive activities of Epoprostenol. |
| Bepridil | Dopexamine may decrease the antihypertensive activities of Bepridil. |
| Hydralazine | Dopexamine may decrease the antihypertensive activities of Hydralazine. |
| Polythiazide | Dopexamine may decrease the antihypertensive activities of Polythiazide. |
| Cilazapril | Dopexamine may decrease the antihypertensive activities of Cilazapril. |
| Saprisartan | Dopexamine may decrease the antihypertensive activities of Saprisartan. |
| Spirapril | Dopexamine may decrease the antihypertensive activities of Spirapril. |
| Mibefradil | Dopexamine may decrease the antihypertensive activities of Mibefradil. |
| Tienilic acid | Dopexamine may decrease the antihypertensive activities of Tienilic acid. |
| Debrisoquine | Dopexamine may decrease the antihypertensive activities of Debrisoquine. |
| Sitaxentan | Dopexamine may decrease the antihypertensive activities of Sitaxentan. |
| Ambrisentan | Dopexamine may decrease the antihypertensive activities of Ambrisentan. |
| Diethylnorspermine | Dopexamine may decrease the antihypertensive activities of Diethylnorspermine. |
| Nilvadipine | Dopexamine may decrease the antihypertensive activities of Nilvadipine. |
| Pinacidil | Dopexamine may decrease the antihypertensive activities of Pinacidil. |
| Temocapril | Dopexamine may decrease the antihypertensive activities of Temocapril. |
| Riociguat | Dopexamine may decrease the antihypertensive activities of Riociguat. |
| Macitentan | Dopexamine may decrease the antihypertensive activities of Macitentan. |
| Hexamethonium | Dopexamine may decrease the antihypertensive activities of Hexamethonium. |
| Aliskiren | Dopexamine may decrease the antihypertensive activities of Aliskiren. |
| Nicorandil | Dopexamine may decrease the antihypertensive activities of Nicorandil. |
| Efonidipine | Dopexamine may decrease the antihypertensive activities of Efonidipine. |
| Lacidipine | Dopexamine may decrease the antihypertensive activities of Lacidipine. |
| Manidipine | Dopexamine may decrease the antihypertensive activities of Manidipine. |
| Rauwolfia serpentina root | Dopexamine may decrease the antihypertensive activities of Rauwolfia serpentina root. |
| Enalaprilat | Dopexamine may decrease the antihypertensive activities of Enalaprilat. |
| Selexipag | Dopexamine may decrease the antihypertensive activities of Selexipag. |
| Angiotensin 1-7 | Dopexamine may decrease the antihypertensive activities of Angiotensin 1-7. |
| Imidapril | Dopexamine may decrease the antihypertensive activities of Imidapril. |
| BQ-123 | Dopexamine may decrease the antihypertensive activities of BQ-123. |
| Cicletanine | Dopexamine may decrease the antihypertensive activities of Cicletanine. |
| Dihydralazine | Dopexamine may decrease the antihypertensive activities of Dihydralazine. |
| Zofenopril | Dopexamine may decrease the antihypertensive activities of Zofenopril. |
| Guanoxan | Dopexamine may decrease the antihypertensive activities of Guanoxan. |
| Delapril | Dopexamine may decrease the antihypertensive activities of Delapril. |
| Vincamine | Dopexamine may decrease the antihypertensive activities of Vincamine. |
| Linsidomine | Dopexamine may decrease the antihypertensive activities of Linsidomine. |
| Guanoxabenz | Dopexamine may decrease the antihypertensive activities of Guanoxabenz. |
| Tolonidine | Dopexamine may decrease the antihypertensive activities of Tolonidine. |
| Endralazine | Dopexamine may decrease the antihypertensive activities of Endralazine. |
| Cadralazine | Dopexamine may decrease the antihypertensive activities of Cadralazine. |
| Cyclopenthiazide | Dopexamine may decrease the antihypertensive activities of Cyclopenthiazide. |
| Bietaserpine | Dopexamine may decrease the antihypertensive activities of Bietaserpine. |
| Guanazodine | Dopexamine may decrease the antihypertensive activities of Guanazodine. |
| Methoserpidine | Dopexamine may decrease the antihypertensive activities of Methoserpidine. |
| Guanoclor | Dopexamine may decrease the antihypertensive activities of Guanoclor. |
| Muzolimine | Dopexamine may decrease the antihypertensive activities of Muzolimine. |
| Xipamide | Dopexamine may decrease the antihypertensive activities of Xipamide. |